The Apoe -/- Mouse PhysioLab ® Platform: A Validated Physiologically-based Mathematical Model of Atherosclerotic Plaque Progression in the Apoe -/- Mouse

Motivation: Atherosclerosis is a complex multi-pathway inflammatory disease where accumulation of oxidatively modified lipids and leukocytes in the arterial intima leads to plaque formation over time. Translating Apoe -/- mouse results to the clinical setting is complicated by uncertainty around (a) mechanisms underlying disease etiology, (b) relative importance of these mechanisms as drivers of progression, and (c) how these roles change in response to perturbation by therapeutic intervention or lifestyle changes. Results: We describe a large-scale mechanistic, mathematical model of atherosclerosis in the Apoe -/- mouse and its validation with in vivo Apoe -/- data. Major physiological components include cholesterol/macrophage trafficking, inflammation, endothelial function, oxidative stress, and thrombosis. Heterogeneity in disease progression, observed despite genetic uniformity and experimentally controlled conditions, was captured through “virtual mice”. This model may be used to optimize in vivo experiments and paves the way for a similar modeling approach for human disease. Availability: The model is available by remote desktop client at Apoe.entelos.com.

[1]  T. Osawa,et al.  [Oxidative stress and atherosclerosis]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[2]  Dalin Tang,et al.  Computer simulations of atherosclerotic plaque growth in coronary arteries. , 2010, Molecular & cellular biomechanics : MCB.

[3]  Salvatore Musumeci,et al.  Modeling immune system control of atherogenesis , 2008, Bioinform..

[4]  M. Daemen,et al.  Compensatory Enlargement and Stenosis Develop in ApoE−/− and ApoE*3-Leiden Transgenic Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Antony Vinh,et al.  Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice. , 2008, Cardiovascular research.

[6]  K. Kalunian,et al.  CXCL13 as a marker for outcome of rheumatoid arthritis: comment on the article by Meeuwisse et al. , 2011, Arthritis and rheumatism.

[7]  S. Hatakeyama,et al.  Analyses of Group III Secreted Phospholipase A2 Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and Atherosclerosis* , 2008, Journal of Biological Chemistry.

[8]  Mary R Myerscough,et al.  An ODE Model of Early Stages of Atherosclerosis: Mechanisms of the Inflammatory Response , 2010, Bulletin of mathematical biology.

[9]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[10]  D Poulikakos,et al.  On the influence of variation in haemodynamic conditions on the generation and growth of cerebral aneurysms and atherogenesis: a computational model. , 2007, Journal of biomechanics.

[11]  Vartan Kurtcuoglu,et al.  Computational modeling of coupled blood-wall mass transport of LDL: effects of local wall shear stress. , 2008, American journal of physiology. Heart and circulatory physiology.

[12]  P. Hundelshausen,et al.  Platelets in atherosclerosis , 2011, Thrombosis and Haemostasis.

[13]  Vartan Kurtcuoglu,et al.  Patient-specific three-dimensional simulation of LDL accumulation in a human left coronary artery in its healthy and atherosclerotic states. , 2009, American journal of physiology. Heart and circulatory physiology.

[14]  K. Hirata,et al.  Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[15]  K. Williams,et al.  Lipoprotein retention--and clues for atheroma regression. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Simionescu.  Implications of Early Structural-Functional Changes in the Endothelium for Vascular Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Matthias von Herrath,et al.  Virtual Optimization of Nasal Insulin Therapy Predicts Immunization Frequency to Be Crucial for Diabetes Protection , 2010, Diabetes.

[18]  V. Volpert,et al.  Mathematical modelling of atherosclerosis as an inflammatory disease , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[19]  S. Narumiya,et al.  Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. , 2004, The Journal of clinical investigation.

[20]  J R Walton,et al.  A mathematical model of atherogenesis as an inflammatory response. , 2005, Mathematical medicine and biology : a journal of the IMA.

[21]  S. Holland,et al.  p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. , 2001, The Journal of clinical investigation.

[22]  L. d’Uscio,et al.  Increased vascular biosynthesis of tetrahydrobiopterin in apolipoprotein E-deficient mice. , 2006, American journal of physiology. Heart and circulatory physiology.

[23]  E. Fisher,et al.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K Gadkar,et al.  The Type 1 Diabetes PhysioLab® Platform: a validated physiologically based mathematical model of pathogenesis in the non‐obese diabetic mouse , 2010, Clinical and experimental immunology.

[25]  D. Heistad,et al.  Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Raymond Coleman,et al.  A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. , 2006, Acta histochemica.

[27]  MichaelBöhm,et al.  Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice , 2008 .

[28]  S. Lebrun,et al.  Progression of atherosclerosis in the Apo E-/- model: 12-month exposure to cigarette mainstream smoke combined with high-cholesterol/fat diet. , 2009, Atherosclerosis.

[29]  C. Allaart,et al.  Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint. , 2011, Arthritis and rheumatism.

[30]  G. Nickenig,et al.  Endothelial-Regenerating Cells: An Expanding Universe , 2010, Hypertension.

[31]  S. Nissen,et al.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.

[32]  Qingbo Xu,et al.  Rapid Endothelial Turnover in Atherosclerosis-Prone Areas Coincides With Stem Cell Repair in Apolipoprotein E–Deficient Mice , 2008, Circulation.

[33]  Klaus Ley,et al.  Monocyte and macrophage dynamics during atherogenesis. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[34]  S. Narumiya,et al.  Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice , 2004 .

[35]  S. Lebrun,et al.  Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice. , 2010, Toxicology letters.

[36]  S. Weinbaum,et al.  Computational Stress Analysis of Atherosclerotic Plaques in ApoE Knockout Mice , 2010, Annals of Biomedical Engineering.

[37]  H. Haussmann,et al.  Comparison of fresh and room-aged cigarette sidestream smoke in a subchronic inhalation study on rats. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  N. Leitinger,et al.  Phenotypic modulation of macrophages in response to plaque lipids , 2011, Current opinion in lipidology.

[39]  J. Trimmer,et al.  APPLICATION OF PREDICTIVE BIOSIMULATION TO THE STUDY OF ATHEROSCLEROSIS: DEVELOPMENT OF THE CARDIOVASCULAR PHYSIOLAB ® PLATFORM AND EVALUATION OF CETP INHIBITOR THERAPY , 2007 .

[40]  D. Harrison,et al.  Endothelial Regulation of Vasomotion in ApoE-Deficient Mice: Implications for Interactions Between Peroxynitrite and Tetrahydrobiopterin , 2001, Circulation.

[41]  Ryo Torii,et al.  Computational modeling of LDL and albumin transport in an in vivo CT image-based human right coronary artery. , 2009, Journal of biomechanical engineering.

[42]  Jason L Johnson,et al.  Characteristics of Intact and Ruptured Atherosclerotic Plaques in Brachiocephalic Arteries of Apolipoprotein E Knockout Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[43]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[44]  A. Gotto,et al.  HDL Cholesterol and Protective Factors in Atherosclerosis , 2004, Circulation.